MedPath
TGA Approval

DOVATO 50/300 dolutegravir (as sodium) 50 mg/lamivudine 300 mg tablet bottle (309378)

309378

DOVATO 50/300 dolutegravir (as sodium) 50 mg/lamivudine 300 mg tablet bottle

ViiV Healthcare Pty Ltd

September 12, 2019

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/266d5c86868b70254aa483b349f82815.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/b9c0ff374b8f5f7aec92ef3ad6eee4ad.pdf

Active Ingredients

dolutegravir sodium

lamivudine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DOVATO 50/300 dolutegravir (as sodium) 50 mg/lamivudine 300 mg tablet bottle (309378) - TGA 批准文号 | MedPath